The pathway enrichment analyses demonstrated the onset of cell death programme in CECs, corroborating previous reports showing an increase in expression of genes (such as RGCC and SPARCL1) that induce or respond to apoptosis in endothelial cells of AMD patients (16,60). This evidence concerns the gene SPARCL1 and age-related macular degeneration.